Profile data is unavailable for this security.
About the company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. It also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The Company is present in Europe and the United States.
- Revenue in EUR (TTM)--
- Net income in EUR--
- Incorporated2000
- Employees4.00
- LocationEpigenomics AGGeneststrasse 5BERLIN 10829GermanyDEU
- Phone+49 30243450
- Fax+49 3 024345555
- Websitehttps://www.epigenomics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neovacs SA | 533.41k | -8.74m | 100.77k | 22.00 | -- | 0.00 | -- | 0.1889 | -30,639.66 | -30,639.66 | 1.52 | 138.89 | 0.0099 | -- | 1.84 | 24,245.91 | -16.21 | -24.42 | -17.66 | -28.28 | 5.50 | -232.13 | -1,639.16 | -6,444.71 | -- | -- | 0.0131 | -- | 47,954.95 | -- | -146.40 | -- | 82.72 | -- |
European Institute of Science AB | 67.22k | -233.08k | 138.83k | 2.00 | -- | 2.38 | -- | 2.07 | -3.95 | -3.95 | 1.13 | 1.23 | 0.3042 | 1.80 | 5.71 | 382,435.00 | -105.50 | -93.04 | -115.57 | -103.14 | 54.58 | 66.99 | -346.76 | -518.86 | 8.19 | -- | 0.00 | -- | 13.66 | 8.54 | 0.3974 | -- | -- | -- |
Paion AG | -100.00bn | -100.00bn | 157.53k | 64.00 | -- | -- | -- | -- | -- | -- | -- | -0.4074 | -- | -- | -- | -- | -- | -24.86 | -- | -34.32 | -- | -- | -- | -52.40 | 0.5078 | -- | 1.17 | -- | 366.42 | 41.74 | 97.34 | -- | 129.37 | -- |
Theravet SA | -100.00bn | -100.00bn | 369.50k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Oxurion NV | 84.00k | -11.37m | 428.94k | 20.00 | -- | -- | -- | 5.11 | -32.56 | -32.56 | 0.1116 | -12.06 | 0.0103 | -- | 0.0346 | 4,200.00 | -138.93 | -84.30 | -- | -118.70 | -25.00 | 48.90 | -13,539.29 | -2,008.99 | -- | -1.81 | -- | -- | -55.80 | -45.20 | 40.13 | -- | -65.17 | -- |
Epigenomics AG | -100.00bn | -100.00bn | 440.12k | 4.00 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -68.91 | -- | -80.04 | -- | 12.05 | -- | -562.29 | -- | -- | 1.00 | -- | -62.27 | -26.04 | 74.21 | -- | -50.98 | -- |
2cureX AB | 7.65k | -2.32m | 897.25k | 14.00 | -- | 3.67 | -- | 117.35 | -1.50 | -1.50 | 0.0049 | 0.1582 | 0.0047 | -- | 0.0295 | 6,214.29 | -143.13 | -38.93 | -174.78 | -44.42 | -10,942.53 | -22,717.96 | -30,282.76 | -39,378.78 | -- | -13.61 | 0.00 | -- | 72.22 | -- | -9.23 | -- | -57.30 | -- |
Ovoca Bio PLC | 0.00 | -3.97m | 1.10m | 5.00 | -- | 0.5304 | -- | -- | -0.0392 | -0.0351 | 0.00 | 0.0212 | 0.00 | -- | -- | 0.00 | -88.55 | -25.19 | -100.85 | -27.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 9.05 | -- | -- | -- |
ATTANA AB | 451.78k | -1.07m | 1.10m | 10.00 | -- | 0.7714 | -- | 2.43 | -0.0361 | -0.0361 | 0.0148 | 0.0376 | 0.1715 | -0.4127 | 1.97 | 514,073.00 | -40.63 | -37.18 | -62.57 | -46.66 | 127.26 | 175.97 | -236.92 | -254.69 | 0.4858 | -4.43 | 0.158 | -- | -32.89 | 6.61 | 5.80 | -- | 8.21 | -- |
Diagonal Bio AB | 2.02k | -1.02m | 1.23m | 4.00 | -- | 0.4974 | -- | 609.78 | -0.1407 | -0.1407 | 0.0002 | 0.0704 | 0.0008 | -- | 2.00 | 4,600.00 | -38.99 | -- | -43.85 | -- | -32,443.48 | -- | -50,504.35 | -- | 1.72 | -15.50 | 0.00 | -- | -88.67 | -- | 27.75 | -- | -- | -- |
Private Rented Sector SA | 23.28k | -15.63k | 1.27m | -- | -- | 101.74 | -- | 54.44 | -0.0508 | -0.0508 | 0.0757 | 0.0405 | 0.3935 | -- | 0.4425 | -- | -26.42 | 1,286.86 | -76.74 | -- | -51.98 | -1,929.58 | -67.14 | 2,759.04 | -- | -1,111.50 | 0.00 | -- | -- | -- | -57.33 | -- | -- | -- |
Circio Holding ASA | 10.43k | 806.35k | 1.29m | 8.00 | 0.904 | -- | 1.47 | 123.20 | 0.6836 | 0.6836 | 0.0156 | -4.05 | 0.0043 | -- | 0.0145 | 11,181.82 | 33.11 | -46.58 | -- | -53.40 | -- | -- | 7,730.08 | -6,902.00 | -- | -- | -- | -- | -98.77 | 35.43 | 74.42 | -- | -- | -- |